Streetbeat News

Stock Prices

FXI

China plans to leverage state-owned enterprises to expand job opportunities across various sectors. This move could impact ETFs like FXI, which tracks large-cap Chinese companies, as it may influence the performance of these enterprises.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:56 am

META

MU

NVDA

QQQ

SPY

US stocks may face some weakness as traders position defensively ahead of key events. Micron's earnings and Meta's event are in focus. The S&P 500 hit record highs, and analysts are optimistic about Q4. Major indices showed mixed performance, with Nvidia boosting tech stocks.

Portfolio Pulse from Shanthi Rexaline

September 25, 2024 | 10:52 am

TH

Target Hospitality has announced the disbandment of its Special Committee, which was composed entirely of independent directors. This decision may impact the company's governance and strategic decision-making processes.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:49 am

LLY

Eli Lilly's Ebglyss treatment for moderate-to-severe atopic dermatitis shows promising long-term results. Over 80% of patients who responded at week 16 maintained skin clearance for up to three years with monthly maintenance dosing.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:48 am

AVGO

IWF

XLK

FS has announced new 400G and 800G Ethernet switches powered by Broadcom's Tomahawk 5 chipset, targeting AI, big data, and HPC applications. Broadcom's AI business is expected to grow significantly, with a projected CAGR of 30%-40% over the next few years. Broadcom's stock has risen 110% in the past year, and investors can gain exposure through ETFs like XLK and IWF.

Portfolio Pulse from Anusuya Lahiri

September 25, 2024 | 10:47 am

MRK

Merck announced that its Phase 3 KEYFORM-007 trial, testing a fixed-dose combination of Favezelimab and Keytruda (Pembrolizumab), did not meet the primary endpoint of overall survival in patients with previously treated PD-L1 positive microsatellite stable metastatic colorectal cancer.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:47 am

ORAN

Orange plans to voluntarily delist from the NYSE and deregister with the SEC, while maintaining its ADR program for trading on the U.S. OTC market. This move aims to simplify operations and reduce costs, without affecting its U.S. commercial presence.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:33 am

ISPO

Inspirato has entered into an equity distribution agreement with Northland Securities to offer common stock worth up to $10.7 million. This move could impact Inspirato's stock price as it may lead to dilution of existing shares.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:18 am

DAT

RVER

SNOW

Snowflake Inc. plans to raise $1.97 billion through a debt offering of convertible senior notes due in 2027 and 2029. The company aims to use the proceeds for capped call transactions, stock repurchase, and general corporate purposes. Snowflake's shares are trading lower premarket.

Portfolio Pulse from Lekha Gupta

September 25, 2024 | 10:09 am

BAC

SPY

Bank of America's CFO, Alastair Borthwick, has projected a terminal interest rate of 2.75% to 3%. This forecast could influence financial markets and interest rate-sensitive sectors.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 9:38 am